1. Home
  2. SPRC vs MBIO Comparison

SPRC vs MBIO Comparison

Compare SPRC & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • MBIO
  • Stock Information
  • Founded
  • SPRC 2004
  • MBIO 2015
  • Country
  • SPRC Israel
  • MBIO United States
  • Employees
  • SPRC N/A
  • MBIO N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • MBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • MBIO Health Care
  • Exchange
  • SPRC Nasdaq
  • MBIO Nasdaq
  • Market Cap
  • SPRC 2.3M
  • MBIO 7.9M
  • IPO Year
  • SPRC N/A
  • MBIO N/A
  • Fundamental
  • Price
  • SPRC $0.23
  • MBIO $0.22
  • Analyst Decision
  • SPRC
  • MBIO Strong Buy
  • Analyst Count
  • SPRC 0
  • MBIO 1
  • Target Price
  • SPRC N/A
  • MBIO $2.00
  • AVG Volume (30 Days)
  • SPRC 872.6K
  • MBIO 391.7K
  • Earning Date
  • SPRC 11-28-2024
  • MBIO 11-12-2024
  • Dividend Yield
  • SPRC N/A
  • MBIO N/A
  • EPS Growth
  • SPRC N/A
  • MBIO N/A
  • EPS
  • SPRC N/A
  • MBIO N/A
  • Revenue
  • SPRC $2,879,000.00
  • MBIO N/A
  • Revenue This Year
  • SPRC N/A
  • MBIO N/A
  • Revenue Next Year
  • SPRC N/A
  • MBIO N/A
  • P/E Ratio
  • SPRC N/A
  • MBIO N/A
  • Revenue Growth
  • SPRC 113.73
  • MBIO N/A
  • 52 Week Low
  • SPRC $0.21
  • MBIO $0.13
  • 52 Week High
  • SPRC $14.22
  • MBIO $2.11
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 36.75
  • MBIO 40.01
  • Support Level
  • SPRC $0.22
  • MBIO $0.21
  • Resistance Level
  • SPRC $0.25
  • MBIO $0.24
  • Average True Range (ATR)
  • SPRC 0.02
  • MBIO 0.02
  • MACD
  • SPRC 0.01
  • MBIO 0.00
  • Stochastic Oscillator
  • SPRC 34.50
  • MBIO 20.25

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: